Starling Oncology (STLN) Revenue (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Revenue (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.84 Bn | 89.83 Bn | 15.19 Bn | 20.23 Bn |
| 2 | Tenet Healthcare | 22.03 Bn | 19.86 Bn | 4.45 Bn | 5.63 Bn |
| 3 | Encompass Health | 12.06 Bn | 11.92 Bn | 1.34 Bn | 1.60 Bn |
| 4 | Davita | 11.84 Bn | 11.15 Bn | 1.16 Bn | 3.55 Bn |
| 5 | Universal Health Services | 10.17 Bn | 10.03 Bn | 3.29 Bn | 4.64 Bn |
| 6 | Ensign | 9.99 Bn | 9.67 Bn | 306.24 Mn | 1.44 Bn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 673.25 Mn |
| 8 | Pacs | 6.67 Bn | 6.51 Bn | 338.46 Mn | 1.43 Bn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 606.03 Mn |
| 10 | Starling Oncology | 616.64 Mn | 575.55 Mn | 27.17 Mn | 161.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161.28 Mn |
| Mar 31, 2026 | 147.44 Mn |
| Dec 31, 2025 | 141.96 Mn |
| Sep 30, 2025 | 136.56 Mn |
| Jun 30, 2025 | 119.80 Mn |
| Mar 31, 2025 | 104.41 Mn |
| Dec 31, 2024 | 100.27 Mn |
| Sep 30, 2024 | 99.90 Mn |
| Jun 30, 2024 | 98.58 Mn |
| Mar 31, 2024 | 94.67 Mn |
| Dec 31, 2023 | 85.79 Mn |
| Sep 30, 2023 | 82.04 Mn |
| Jun 30, 2023 | 80.22 Mn |
| Mar 31, 2023 | 76.19 Mn |
| Dec 31, 2022 | 71.42 Mn |
| Sep 30, 2022 | 64.98 Mn |
| Jun 30, 2022 | 60.92 Mn |
| Mar 31, 2022 | 55.16 Mn |
| Dec 31, 2021 | 52.30 Mn |
| Sep 30, 2021 | 52.28 Mn |